XPW1
XPW1 is a potent and selective CDK9 inhibitor with excellent activity against clear cell renal cell carcinoma (ccRCC) and low toxicity[1].
Product Specifications
CAS Number
2700286-66-2
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/xpw1.html
Purity
99.27
Solubility
DMSO : 31.25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(N[C@H]1CC[C@H](NC2=NC=C(Cl)C(C3=NC(NCC4=CC=CC(F)=C4)=CC=C3)=C2)CC1)C5=CC=C(NC(/C=C/CN(C)C)=O)C=C5
Molecular Formula
C36H39ClFN7O2
Molecular Weight
656.19
References & Citations
[1]Kuang Z, et al. The novel CDK9 inhibitor, XPW1, alone and in combination with BRD4 inhibitor JQ1, for the treatment of clear cell renal cell carcinoma. Br J Cancer. 2023 Oct 26.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
EK1F936 96 Tests
Equine Platelet Activating Factor (PAF) ELISA Kit-Competitive
Sign In for Pricing
View Details 
MBS4380053-01 0.02 mg (With BSA & Azide at 0.2mg/mL)
gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker) Mouse Monoclonal Antibody
Sign In for Pricing
View Details